The devolved Welsh Government plans to expand the use of an artificial intelligence-powered tool used to spot cancer in biopsy samples, after seeing a 13% increase in pros
Patients in Wales with a rare disease that causes epilepsy will be the first in the UK to get access to GW Pharma's cannabis-based medicine Epidyolex, after the drug was cleared for use by
A new organisation dedicated to increasing the use of digital health in the NHS in Wales has come into being, 18 months after the move was first unveiled by the Welsh government. <
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies.
Patients in Wales are to gain faster access to medicines recommended by NICE and Wales’ own cost-effectiveness body, the All Wales Medicines Strategy Group (AWMSG).
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS